BEATRICE MAY: Open Payments
NPI 1881197804 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $108 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $96 |
| Alkermes, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, LYBALVI, FANAPT, REXULTI.
Industry payments across OR — which companies pay providers there.
